Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience

NCT05182203 is registered in ClinicalTrials.gov with Tuen Mun Hospital as lead sponsor.

NCT NCT05182203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05182203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience
Lead sponsor
Tuen Mun Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2022
Completion date
October 1, 2022
Enrollment
1,732 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug use, rheumatoid arthritis